Vol. 10, Issue 5 (2021)

Author(s):
Diksha Kumari, Bishun Deo Prasad, Padmanabh Dwivedi and Sangita Sahni

Abstract:
The current pandemic situation of COVID-19 incites the researchers to find out vaccines to control SARS-CoV-2. The basis of vaccine designing strategy for COVID-19 has been taken from various published research articles on SARS-CoV and MERS. COVID-19 vaccination efforts have been started in earlier days of infection of COVID-19 in China and a few days later it started worldwide. This pathetic condition evolved race for vaccine development. An accelerated vaccine development program was launched in several countries worldwide in which several steps were done in parallel. In this review we have described the various vaccines viz. subunit, mRNA, DNA, inactivated and vector-based vaccine, which have been already signified demonstrated their therapeutic and prophylactic response against SARS-CoV-2, after that released for vaccination. Many vaccines were released to control SARS-CoV-2 with different efficacy and safety.